Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| WIP | 38.79 | -0.08 | -0.21% |
| SPDR® FTSE Intl Govt Infl-Protd Bd ETF | |||
| XTWY | 38.71 | -0.09 | -0.24% |
| BondBloxx Bloomberg TwentyYrTrgDuUSTrETF | |||
| QQJG | 26.49 | -0.12 | -0.45% |
| Invesco ESG NASDAQ Next Gen 100 ETF | |||
| ICF | 60.11 | -0.51 | -0.83% |
| iShares Select U.S. REIT ETF | |||
| SPMC | 15.07 | -0.50 | -3.21% |
| Sound Point Meridian Capital, Inc. | |||
A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.
| Ticker / NAME | Correlation To ROQAF | 1D Price Change % | ||
|---|---|---|---|---|
| ROQAF | 100% | N/A | ||
| GNTA - ROQAF | 36% Loosely correlated | -1.94% | ||
| CRBP - ROQAF | 22% Poorly correlated | +7.02% | ||
| SVRA - ROQAF | 21% Poorly correlated | -0.71% | ||
| SKYE - ROQAF | 21% Poorly correlated | -4.29% | ||
| SNTI - ROQAF | 6% Poorly correlated | +18.62% | ||
More | ||||